![](https://investorshub.advfn.com/uicon/471992.png?cb=1695152368)
Wednesday, March 02, 2022 2:45:03 PM
Canopy’s suit vs GW ends, with ruling in favor of GW
“Final judgment of noninfringement as to all allegations”
Canopy “cannot prevail on the issue of infringement of the ’632 Patent, literally or under the doctrine of equivalents”
Woops there goes CGC's medical cannabis in the UK. CGC losers again!
Epidiolex—can’t infringe Canopy’s patent?
— Graham Pechenik (@calyxlaw) March 2, 2022
Canopy’s suit vs GW ends, with ruling in favor of GW
“Final judgment of noninfringement as to all allegations”
Canopy “cannot prevail on the issue of infringement of the ’632 Patent, literally or under the doctrine of equivalents”
1/2 https://t.co/6qpwUnXqGp
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM